This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Capricor, Inc., Cedars-Sinai Medical Center. Active years: 2023.
Company Filing History:
1 out of 6 
1 out of 627 
Years Active: 2023
Title: Jennifer Moseley: Innovator in Muscular Dystrophy Treatment
Introduction
Jennifer Moseley is a prominent inventor based in Los Angeles, CA, who has made significant contributions to the field of medical science. She holds a patent that focuses on innovative methods for treating skeletal muscular dystrophy, particularly Duchenne muscular dystrophy (DMD). Her work aims to improve the quality of life for patients suffering from this debilitating condition.
Latest Patents
Jennifer Moseley is credited with a patent titled "Methods and compositions for treating skeletal muscular dystrophy." This patent outlines a method of treating skeletal muscular myopathy using cardiosphere-derived cells (CDCs). The invention details the delivery of a therapeutically effective amount of CDCs to targeted dystrophic skeletal muscle through various administration routes, including intramuscular injection and intravenous injection. Additionally, her patent discusses methods for enhancing exercise capabilities in DMD patients and the role of exosome-mediated transfer of noncoding RNAs in restoring dystrophin levels in heart and skeletal muscle.
Career Highlights
Throughout her career, Jennifer has worked with esteemed organizations such as Cedars-Sinai Medical Center and Capricor, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field, further advancing her research and innovations.
Collaborations
Jennifer has collaborated with notable professionals, including Eduardo Marban and Russell Thomas Rogers. These partnerships have contributed to her success and the development of her groundbreaking patent.
Conclusion
Jennifer Moseley's innovative work in the treatment of muscular dystrophy showcases her dedication to improving patient outcomes. Her patent represents a significant advancement in medical science, offering hope to those affected by DMD.